47 results
8-K
EX-99.6
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
, development, testing, manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, marketing … for testing the identity, strength, quality and purity of the final drug. In addition, appropriate packaging must be selected and tested and stability
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
, packaging, distribution, storage, advertising, promotion, import, export, recordkeeping, monitoring and reporting for Kineta’s product will be subject
424B3
9h4z6
10 Nov 22
Prospectus supplement
4:21pm
425
gswgp4l
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.1
grkr94f
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm